| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $106.0M | — | +2.1% |
| Cost of Revenue | $48.0M | — | +8.8% |
| Gross Profit | $58.0M | — | -2.9% |
| R&D Expense | $3.7M | — | +31.3% |
| SG&A Expense | $18.8M | — | -22.5% |
| Operating Income | -$81.0M | — | +83.6% |
| Pre-tax Income | -$82.1M | — | +83.5% |
| Income Tax | -$11.4M | — | -143.0% |
| Net Income | -$70.8M | — | +86.5% |
| EPS (Basic) | -$0.98 | — | +86.6% |
| EPS (Diluted) | -$0.98 | — | +86.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.7M | +17.4% | -39.3% |
| Accounts Receivable | $66.4M | -20.8% | -2.5% |
| Current Assets | $147.9M | -4.8% | -15.2% |
| Total Assets | $877.9M | -6.3% | -41.7% |
| Current Liabilities | $128.1M | +1.2% | -29.9% |
| Total Liabilities | $353.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$57K | — | -100.5% |
| Capital Expenditures | $53K | — | +76.7% |
| Investing Cash Flow | -$5.9M | — | -108.2% |
| Financing Cash Flow | $13.1M | — | +104.7% |
| Free Cash Flow | -$110K | — | -100.9% |
| -21.4% |
| Stockholders' Equity | $524.5M | -11.8% | -50.3% |